Z-2041-2025 Class II Ongoing

Recalled by Hardy Diagnostics — Santa Maria, CA

FDA device recall Z-2041-2025 was initiated by Hardy Diagnostics on May 6, 2025 and is designated Class II. Reason for recall: Identified lots failed incoming quality control testing. Lots exhibited breakthrough growth of Klebsiella pneumoniae. The recall status is ongoing. Affected quantity: 4300 ea.

Recall details

Product Type
Devices
Report Date
Jul 9, 2025
Initiation Date
May 6, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4300 ea

Product description

HardyCHROM CRE, selective and differential culture medium for antimicrobial susceptibility testing, Product Catalog No. G323

Reason for recall

Identified lots failed incoming quality control testing. Lots exhibited breakthrough growth of Klebsiella pneumoniae.

Distribution pattern

US domestic distribution to the following states: AZ, CA, CO, FL, GA, IL, MD, ME, MI, MN, MO, NC, NE, NV, NY, PA, PR, TX, UT, VA, WI and WV.

Code information

UDI-DI 008165760257704 G323 lot 653594P: Manufactured on March 6, 2025; Expires on May 15, 2025 G323 lot 655101P: Manufactured on April 4, 2025; Expires on June 13, 2025 G323 lot 656816P: Manufactured on April 16, 2025; Expires on June 25, 2025

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-2041-2025
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-2041-2025. Report a data issue: hello@regdatalab.com.